Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

Compare more Cancer Research professors.

h-index79
i10-index405
Publications1,434
Citations32,181

Grants

2 total · 1 active

NIH #R01CA273168

Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold

Active
Amount
$600K–$700K
Period
2022-07-01 → 2027-06-30
PIs
3

Awarded at UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR

NIH #R01CA242845

Blocking tumor progression in therapy-responsive RET aberration-associated cancer

Amount
$400K–$500K
Period
2020-09-01 → 2025-05-31
PIs
3

Awarded at UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

2 total · 1 active

NIH #R01CA273168

Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold

Active
Amount
$600K–$700K
Period
2022-07-01 → 2027-06-30
PIs
3

Awarded at UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR

NIH #R01CA242845

Blocking tumor progression in therapy-responsive RET aberration-associated cancer

Amount
$400K–$500K
Period
2020-09-01 → 2025-05-31
PIs
3

Awarded at UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR

Recent Public Signals

  1. New paper: Beyond one gene, one target: Next-generation precision oncology (Trends in cancer)2026-06-01
  2. New NIH award: Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold2022-07-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-30

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0002-6064-6837

Professor Insights

Career Trajectory